Delivery Order SPE2DR25D6029-SPE2DR26FXQ1M
- Not listed
- The Defense Logistics Agency awarded a $1,644.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Crexont ER 87.5 mg-350 mg capsules (120 count) on September 26, 2025, with completion expected by September 29, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The prime contract serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $5,255.04 to AmerisourceBergen Drug Corp for Crexont ER 87.5 mg-350 mg capsules (120 count) on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed price contract was issued without a set-aside designation and will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,179.35 to AmerisourceBergen Drug Corp for CREXONT ER 52.5 MG-210 MG capsules (120-count supply) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,539.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CREXONT ER 70 MG-280 MG capsules (120-count) on November 14, 2025, with completion scheduled for November 17, 2025. This is a non-set-aside, competitively awarded contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $6,461.53 to AmerisourceBergen Drug Corp for Crexont ER (52.5 mg-210 mg capsules, quantity 120) with a firm fixed price contract type. The award, issued on October 31, 2025, is non-competitive with an ultimate completion date of November 3, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $5,851.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for CREXONT ER 87.5 MG-350 MG capsules (120-count supply). This non-set-aside competitive award is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $4,030.34 to AmerisourceBergen Drug Corp for the supply of CREXONT ER 87.5 MG-350 MG capsules (120 count) on October 21, 2025, with an ultimate completion date of October 22, 2025. This delivery order represents a firm fixed price contract with no set-aside designation, issued under open competition. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,501.63 to AmerisourceBergen Drug Corp for Crexont ER 70 MG-280 MG capsules (120-count supply) on August 4, 2025, with completion scheduled for August 5, 2025. This non-competitive delivery order utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal...
- The Defense Logistics Agency (DLA) awarded a $5,062.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Crexont ER 52.5 mg-210 mg capsules (120-count units). This non-set-aside award was made on November 14, 2025, with an ultimate completion date of November 17, 2025. The contract is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,315.07, is for the delivery of 4567615784 ! CREXONT ER 87.5 MG-350 MG CAP 120S, a medical product, with a performance period ending on March 19, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
- SPE2DR25D6029Indefinite Delivery Contract
- SPE2DR25D6029-SPE2DR26FXQ1MDelivery Order
The Defense Logistics Agency awarded a $4,684.31 delivery order to AmerisourceBergen Drug Corp for Crexont ER 280 mg capsules (120 count) on November 17, 2025, with completion targeted for November 18, 2025. This is a firm fixed price, non-set-aside contract performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to meet federal medical procurement requirements through competitive awards across multiple therapeutic domains. The company's federal contract portfolio with DLA encompasses diverse pharmaceutical products ranging from specialty medications to vaccines and medical supplies. This particular delivery order for Crexont ER reflects the company's ongoing role as a critical vendor supporting the Defense Health Agency and other federal healthcare systems through the comprehensive pharmaceutical prime vendor framework established by DLA Troop Support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 11/17/25 |